OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Lenvatinib or anti-VEGF in combination with anti–PD-1 differentially augments antitumor activity in melanoma
Thuy Tran, Jasmine I. Caulfield, Lin Zhang, et al.
JCI Insight (2023) Vol. 8, Iss. 7
Open Access | Times Cited: 14
Thuy Tran, Jasmine I. Caulfield, Lin Zhang, et al.
JCI Insight (2023) Vol. 8, Iss. 7
Open Access | Times Cited: 14
Showing 14 citing articles:
Targeting cytokine and chemokine signaling pathways for cancer therapy
Ming Yi, Tianye Li, Mengke Niu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 49
Ming Yi, Tianye Li, Mengke Niu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 49
Antiangiogenic–immune-checkpoint inhibitor combinations: lessons from phase III clinical trials
Hung‐Yang Kuo, Kabir A. Khan, Robert S. Kerbel
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 6, pp. 468-482
Closed Access | Times Cited: 29
Hung‐Yang Kuo, Kabir A. Khan, Robert S. Kerbel
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 6, pp. 468-482
Closed Access | Times Cited: 29
Phase II Trial of Pembrolizumab in Combination With Bevacizumab for Untreated Melanoma Brain Metastases
Sarah A. Weiss, Dijana Djureinovic, Wei Wei, et al.
Journal of Clinical Oncology (2025)
Closed Access | Times Cited: 1
Sarah A. Weiss, Dijana Djureinovic, Wei Wei, et al.
Journal of Clinical Oncology (2025)
Closed Access | Times Cited: 1
Angiogenesis Still Plays a Crucial Role in Human Melanoma Progression
Gerardo Cazzato, Giuseppe Ingravallo, Doménico Ribatti
Cancers (2024) Vol. 16, Iss. 10, pp. 1794-1794
Open Access | Times Cited: 7
Gerardo Cazzato, Giuseppe Ingravallo, Doménico Ribatti
Cancers (2024) Vol. 16, Iss. 10, pp. 1794-1794
Open Access | Times Cited: 7
Determinants of resistance and response to melanoma therapy
Bailey M. Robertson, Mitchell E. Fane, Ashani T. Weeraratna, et al.
Nature Cancer (2024) Vol. 5, Iss. 7, pp. 964-982
Closed Access | Times Cited: 7
Bailey M. Robertson, Mitchell E. Fane, Ashani T. Weeraratna, et al.
Nature Cancer (2024) Vol. 5, Iss. 7, pp. 964-982
Closed Access | Times Cited: 7
MEK inhibitors for the treatment of immunotherapy-resistant, AGK-BRAF fusion advanced acral melanoma: a case report and literature review
Yanling Zhang, Xifeng Zhang, Weikang Shao, et al.
Journal of Cancer Research and Clinical Oncology (2025) Vol. 151, Iss. 4
Open Access
Yanling Zhang, Xifeng Zhang, Weikang Shao, et al.
Journal of Cancer Research and Clinical Oncology (2025) Vol. 151, Iss. 4
Open Access
Acral melanoma: new insights into the immune and genomic landscape
Larissa Anastácio da Costa Carvalho, Flavia C. Aguiar, Keiran S.M. Smalley, et al.
Neoplasia (2023) Vol. 46, pp. 100947-100947
Open Access | Times Cited: 11
Larissa Anastácio da Costa Carvalho, Flavia C. Aguiar, Keiran S.M. Smalley, et al.
Neoplasia (2023) Vol. 46, pp. 100947-100947
Open Access | Times Cited: 11
Vascular mimicry as a facilitator of melanoma brain metastasis
Olivia K. Provance, Victor O. Oria, Thuy Tran, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 3
Olivia K. Provance, Victor O. Oria, Thuy Tran, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 3
Recent advances in tyrosine kinase inhibitors VEGFR 1-3 for the treatment of advanced metastatic melanoma
Paweł Sobczuk, Michał Cholewiński, Piotr Rutkowski
Expert Opinion on Pharmacotherapy (2024) Vol. 25, Iss. 5, pp. 501-510
Closed Access | Times Cited: 2
Paweł Sobczuk, Michał Cholewiński, Piotr Rutkowski
Expert Opinion on Pharmacotherapy (2024) Vol. 25, Iss. 5, pp. 501-510
Closed Access | Times Cited: 2
Real-world outcomes of combined lenvatinib and anti-PD-1 in advanced melanoma: the Lenvamel study, a multicenter retrospective study of the French Group of Skin Cancers (Groupe de Cancérologie Cutanée)
Perrine Rousset, Charlée Nardin, E. Maubec, et al.
The Oncologist (2024) Vol. 29, Iss. 10, pp. e1364-e1372
Open Access | Times Cited: 1
Perrine Rousset, Charlée Nardin, E. Maubec, et al.
The Oncologist (2024) Vol. 29, Iss. 10, pp. e1364-e1372
Open Access | Times Cited: 1
Letrozole‐Based Near‐Infrared Dynamic Imaging Targeting Ductal‐Vascular RhoJ From Pancreatic Intraepithelial Neoplasia to Pancreatic Ductal Adenocarcinoma
Zhi Cao, Zhuang Hu, Yishu Wang, et al.
Advanced Healthcare Materials (2024)
Closed Access
Zhi Cao, Zhuang Hu, Yishu Wang, et al.
Advanced Healthcare Materials (2024)
Closed Access
A targetable developmental program co-regulates angiogenesis and immune evasion
Pietro Berico, Amanda Flores Yanke, Fatemeh Van Rajabpour, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access
Pietro Berico, Amanda Flores Yanke, Fatemeh Van Rajabpour, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access
Harnessing Immunity to Treat Advanced Thyroid Cancer
Hiroki Komatsuda, Michihisa Kono, Risa Wakisaka, et al.
Vaccines (2023) Vol. 12, Iss. 1, pp. 45-45
Open Access | Times Cited: 1
Hiroki Komatsuda, Michihisa Kono, Risa Wakisaka, et al.
Vaccines (2023) Vol. 12, Iss. 1, pp. 45-45
Open Access | Times Cited: 1
Kinase Insert Domain Receptor Q472H Pathogenic Germline Variant Impacts Melanoma Tumor Growth and Patient Treatment Outcomes
Milad Ibrahim, Irineu Illa-Bochaca, Faisal Fa’ak, et al.
Cancers (2023) Vol. 16, Iss. 1, pp. 18-18
Open Access
Milad Ibrahim, Irineu Illa-Bochaca, Faisal Fa’ak, et al.
Cancers (2023) Vol. 16, Iss. 1, pp. 18-18
Open Access
